DB22406InvestigationalCell transplant therapies
GC012F is under investigation in clinical trial NCT06419166 (An Exploratory Clinical Study of GC012F Injection for Refractory gMG).
- Mechanism
- Curator reviewed
Pharmacologically active on B-lymphocyte antigen CD19 and Tumor necrosis factor receptor superfamily member 17
- Code names
- AZD0120 · GC012F
Resolves to
Targets
What you can answer from here — as of June 26, 2026
Which drugs share a target with GC012F, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account